CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

vitamin k2

Small moleculeexperimental

Vitamin K2 or menaquinone (MK) is one of three types of vitamin K, the other two being vitamin K1 (phylloquinone) and K3 (menadione). K2 is both a tissue and bacterial product (derived from vitamin K1 in both cases) and is usually found in animal products or fermented foods. — Wikipedia

Clinical trial activity

21 trials · 33 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
5
Phase 3
4
Phase 4
1

Earliest trial started May 1, 2017 (NCT03799822)

Timeline

2010s

  1. Jan 1, 2019

    Earliest Phase 2 Sponsor(trial)

2020s

  1. Jan 1, 2021

    Earliest Phase 3 Sponsor(trial)

  2. Jan 1, 2024

    Earliest Phase 1 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

  • Unspecified targetAntioxidant

    Antioxidant

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06817512N/AFeb 15, 2025Harbin Medical University
NCT06385275Phase 1/Phase 2 (Phase 2)Dec 31, 2024Boston University, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NCT05995522N/ASep 1, 2023University of Guadalajara
NCT05675163N/ANov 15, 2022Kappa Bioscience, NIZO Food Research
NCT05547750Phase 2Oct 1, 2022North Sichuan Medical University, Sichuan University
NCT05417880Phase 3Aug 31, 2022Scotmann Pharmaceuticals, Sir Syed Medical hospital, Khi College of Sciences & Qayyumabad,Khi, University of Health Sciences Lahore
NCT05356936N/AJun 1, 2022Case Western Reserve University
NCT05375630N/AMar 21, 2022Dasman Diabetes Institute, Kappa Bioscience
NCT05161975N/ADec 15, 2021Government of Lithuania, Kappa Bioscience, Lithuanian Sports University
NCT04900610N/ASep 30, 2021Aristotle University of Thessaloniki, Nattopharma
NCT04780061Phase 3Jul 12, 2021New Roots Herbal, The Canadian College of Naturopathic Medicine, University of Ottawa, Vitazan Professional
NCT04676958N/AApr 1, 2021Kappa Bioscience, University of Glasgow
NCT04770740Phase 2Feb 22, 2021Canisius-Wilhelmina Hospital, Kappa Bioscience
NCT04477811Phase 2/Phase 3 (Phase 3)Jul 25, 2020Ain Shams University
NCT05360342N/AMar 31, 2020RWTH Aachen University
NCT04429035N/ASep 23, 2019University of Athens
NCT04145492Phase 2/Phase 3 (Phase 3)Sep 1, 2019Ain Shams University
NCT03871322N/AJun 1, 2019International Science & Health Foundation, Lomza State University of Applied Sciences, Medical University of Bialystok, Tenet Healthcare Corporation
NCT03897660N/AMar 29, 2019University of Sherbrooke
NCT03493087N/AFeb 22, 2018University of Copenhagen
Showing 20 of 21 trials
Page 1 / 2

Organizations

Research & Development (33)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Kappa BioscienceFor profit5022021
Ain Shams UniversityAcademic/Hospital2212019
Aristotle University of ThessalonikiAcademic/Hospital1112021
Boston UniversityAcademic/Hospital1112024
Canisius-Wilhelmina HospitalAcademic/Hospital1112021
Case Western Reserve UniversityAcademic/Hospital1112022
Dasman Diabetes InstituteAcademic/Hospital1112022
Government of LithuaniaGovernment1012021
Harbin Medical UniversityAcademic/Hospital1112025
International Science & Health FoundationAcademic/Hospital1012019
Lithuanian Sports UniversityAcademic/Hospital1112021
Lomza State University of Applied SciencesAcademic/Hospital1012019
Medical University of BialystokAcademic/Hospital1112019
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Government1012024
NattopharmaFor profit1012021
New Roots HerbalFor profit1012021
NIZO Food ResearchFor profit1112022
North Sichuan Medical UniversityAcademic/Hospital1012022
Onze Lieve Vrouw HospitalAcademic/Hospital1112017
RWTH Aachen UniversityAcademic/Hospital1112020
33 organizations
Page 1 / 2